Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

NCT06348147 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

39

Enrollment

OTHER

Sponsor class

Stopped budget

Conditions

Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Autologous Stem Cell Transplantation

Interventions

BIOLOGICAL: Daratumumab
DRUG: Lenalidomide
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

UNC Lineberger Comprehensive Cancer Center